Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02ZZU
|
||||
| Former ID |
DNCL002233
|
||||
| Drug Name |
DM-CHOC-PEN
|
||||
| Indication | Brain cancer [ICD9: 191, 225.0; ICD10:C71, D33] | Phase 2 | [1] | ||
| Company |
Dekk-Tec
|
||||
| Structure |
|
Download2D MOL |
|||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029242) | ||||
| REF 2 | Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents. Cancer Chemother Pharmacol. 2009 September; 64(4): 829-835. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.